GR-MD-02
15-166
Phase 1 small_molecule completed
Quick answer
GR-MD-02 for Melanoma is a Phase 1 program (small_molecule) at GALECTIN THERAPEUTICS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- GALECTIN THERAPEUTICS INC
- Indication
- Melanoma
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed